📰 Achexin News
Achexin News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Achexin. Real-time updates on events, politics, business and more.
March 29, 2024
Short-term exposure to high outdoor temperatures may impair the immune system, rendering people more prone to infection and possibly accelerating heart disease progression.
October 28, 2023
Among the objectives of the study, which aims to enroll 8000 patients with HS, is to collect biospecimens from patients for translational studies.
October 10, 2023
This new route of administration is expected to become available during the fourth quarter of 2023.
June 27, 2023
The novel IL-1 inhibitor goflikicept is effective and relatively safe in idiopathic recurrent pericarditis.
April 10, 2023
A network meta-analysis ranked eight therapies for ulcerative colitis based on how fast they acted to relieve symptoms, with upadacitinib appearing most effective and ozanimod least effective.
November 9, 2022
Compared with conventional synthetic disease-modifying antirheumatic drugs (DMARDs), biologic and targeted synthetic DMARDs may lower dementia risk.
August 12, 2022
The highest prevalence of HS is among people in their 20s and 30s, so clinicians are likely to encounter female patients with HS who are either pregnant or actively thinking about getting pregnant.
July 15, 2022
Similar benefits were seen with low, moderate, and high statin doses, as well as in cases of both mild and severe acute pancreatitis.
June 2, 2022
Subquantifiable brodalumab levels were associated with a lack of response after 12 weeks, in the retrospective study.
February 25, 2022
More studies are needed to determine if the results are applicable to other populations and how air pollution might affect psoriasis disease activity, the investigators write.